Demant, DK0010268440

Demant consensus picture on Tuesday, analysts keep a clear Buy stance on the shares

Published on 06/25/2026 at 13:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Demant faces the week with a solid analyst backdrop. Nineteen brokers tracked by Investing.com rate the Copenhagen-listed hearing-aid specialist a Buy on average, with only Hold recommendations alongside and no Sell calls in the current consensus.

Demant, DK0010268440, Illustration mit AI erstellt.
Demant, DK0010268440, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 13:34.

Demant (DK0010268440) opens Tuesday trading in Copenhagen with a robust analyst consensus backdrop. According to Investing.com, 19 analysts cover the stock and the average recommendation stands at Buy for the OMX-listed hearing-aid group.Consensus data on Demant from Investing.com

What analysts currently expect

The consensus compiled by Investing.com shows 13 Buy ratings, 6 Hold ratings and no Sell recommendations on Demant, pointing to a clear positive stance among brokers.Demant analyst breakdown on Investing.com The average 12-month price target sits at 256.9 Danish kroner (DKK), with estimates ranging from 215 DKK on the low side to 290 DKK on the high side.Demant price targets overview

How the stock trades in Copenhagen

On Nasdaq Copenhagen, Demant recently changed hands at 265.60 DKK, according to Financial Times market data, implying a modest downside of around 3.5 percent versus the analyst average target.FT snapshot of Danish equities including Demant Over a 12-month period, the shares have delivered a positive performance, with the current level above the consensus average but inside the published target range between 215 DKK and 290 DKK.Demant target range vs. last price

Go deeper

All news and analysis on the Demant shares

Historic articles, price data and further background on Demant can be found in the dedicated topic area on ad-hoc-news.de and via the company’s Investor Relations section.

How Demant earns its money

Demant generates most of its revenue with hearing healthcare products and services, centered on digital hearing aids under brands such as Oticon and Bernafon, hearing care retail chains, and diagnostics equipment including audiometers and fitting systems.Demant Investor Relations overview of business segments

Where the shares trade now

The Demant shares (DK0010268440) trade on 2026-06-25, 13:30 on Nasdaq Copenhagen at 265.60 DKK.

Demant key data at a glance

  • Company: Demant A/S
  • ISIN: DK0010268440
  • WKN: 894391
  • Ticker: DEMANT
  • Trading venue: Nasdaq Copenhagen
  • Price (as of 2026-06-25, 13:30): 265.60 DKK
  • Market cap: 222.0 billion DKK (as of 2026-06-25)
  • Sector / industry: Health Care / Medical Devices & Equipment
  • Index membership: OMX Copenhagen 25
  • Next earnings date: not officially scheduled

More on Demant in social media

This text is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DK0010268440 | DEMANT | boerse | 69623235 | bgmi